Drug Approval | March 11, 2023
USFDA completes inspection of Lupin’s Vizag facility
The inspection concluded with no observations
The inspection concluded with no observations
Chronic Kidney Disease is a growing epidemic with 850 million people affected worldwide.
Resomer used in commercial 3D-printed implants for both soft and hard tissue applications
The new powder flow tester can characterize powder flow properties, offering valuable insight for pharmaceutical processing and formulation
Digital success is contingent on the way a company organizes itself around technology
The common stock of Concert will no longer be listed for trading on the Nasdaq Global Market
The company operates 25 CT Scanners, 6 new MRI Machines, 30 Pathological Laboratories, 1 Referral Laboratory, and 95 Collection Centers
The audit was commenced for newly renovated manufacturing Block 1, Block 2, and Block 3
The company expects the GMP approval from Saudi Food and Drug Authority (SFDA) to soon pave the way for marketing authorizations from the largest market in the GCC region
First release of Rs.166 crores incentives under PLI scheme for pharmaceuticals
Subscribe To Our Newsletter & Stay Updated
